Labopharm Announces its Once-Daily Tramadol Approved for Sale in Canada.
M2 Presswire, June, 2007
 | Content provided in partnership with |  |
M2 PRESSWIRE-18 June 2007-Morning Movers: Labopharm Announces its Once-Daily Tramadol Approved for Sale in Canada(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:18062007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets.
- Most Popular Articles in News
- The Ten Best Laptop bags
- Tata plans cheapest-ever car for Indian market
- GLOBALIZATION AND THE DEVELOPMENT OF UNDERDEVELOPMENT OF THE THIRD WORLD
- Corn is good for you; Corn is not only a tasty treat, but also a cereal that ...
- THE 50 BEST STYLISH HANDBAGS TO CARRY
- More »
Activity on the Toronto market has brought this company to the attention of our research team. Labopharm Inc. (TSX: DDS), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the ...
Read the rest of this article with a Free Trial at HighBeam Research.Find Research Guides for:
Find Featured Titles for: Reference
- Academe
- African American Review
- African Arts
- African Studies Review
- Afro-Americans in New York Life and History
- Alabama Heritage
- Alabama Review
- American Mathematical Monthly, The
- Anglican Theological Review
- Annals of Dyslexia
- Arab Studies Quarterly (ASQ)
- Auk, The
- Australian Journal of Anthropology, The
- Christian Century
- Natural History